Jiho Song Selected Research

MMS 1001

3/2013

MMS 1001 inhibits melanin synthesis via ERK activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiho Song Research Topics

Disease

3	Neoplasms (Cancer) 12/2018 - 01/2015
2	Melanoma (Melanoma, Malignant) 03/2013 - 11/2012
1	Leukemia 01/2021
1	Cataract (Cataracts) 01/2020
1	Epiretinal Membrane (Epiretinal Membranes) 01/2020
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 02/2019
1	Skin Neoplasms (Skin Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

1	Histone MethyltransferasesIBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2020
1	25-hydroxycholesterolIBA 02/2019
1	cholesterol 25-hydroxylaseIBA 02/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	miltefosine (Impavido)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 12/2018
1	MicroRNAs (MicroRNA)IBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	Angiogenesis InhibitorsIBA 01/2015
1	MMS 1001IBA 03/2013
1	alpha-MSHIBA 03/2013
1	IsoxazolesIBA 11/2012
1	Melanocyte-Stimulating Hormones (MSH)IBA 11/2012

Therapy/Procedure

1	Vitrectomy 01/2020
1	Drug Therapy (Chemotherapy) 01/2015
1	Therapeutics 01/2015